1.Diagnosis and Therapeutic Optin of Rnovasular Hypertension.
Journal of the Korean Society for Vascular Surgery 2000;16(1):154-160
No abstract available.
Diagnosis*
;
Hypertension*
2.Application of left ventricular myocardial indicator in the diagnosis
Journal of Practical Medicine 2002;435(11):42-44
The number of people identified as having hypertension continues to increase and most of them have left ventricular hypertrophy - an earlies complication and also being a risk factor of heart disease. In clinical practise in Cardiovascular Department, Hue Central hospital, until now, diagnosis LVH depends on ECG so it miss many cases as having a real LVH. This is the first time, we use echocardiography to diagnose LVH in patients with hypertension by using LVMI. In 56 cases of hypertension we found a larger number of LVH by using LVMI than by ECG (41 cases V¬s 22 cases - p<0.01) This is an method in diagnosis LVH
Hypertension
;
Diagnosis
8.A Case of Curable Renovascular Hypertension Complicated by Renal Artery Embolism.
Hyun Chul KIM ; Hyung Ki CHOI ; Jin Moo LEE
Korean Journal of Urology 1982;23(6):837-840
Renal artery embolism is an uncommon event, but a correct diagnosis and appropriate treatment are often delayed. We report a case in which viability was sustained by surgical intervention 18 hours after an episode of embolism that produced hypertension.
Diagnosis
;
Embolism*
;
Hypertension
;
Hypertension, Renovascular*
;
Renal Artery*
10.Pulmonary hypertension: a review of current clinical practice.
Chinese Journal of Cardiology 2014;42(6):450-452
This short review illustrates current epidemiology, diagnosis and treatment of pulmonary hypertension. In the first part, classification, definition and prevalence of pulmonary hypertension (PH) are explained. According to recent reports, overall PH prevalence was 0.3% to 6.0% with left heart disease occupying the most proportion, followed by pulmonary disease, pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) constituting far less proportion of 10 to 50 per 1 million people. In diagnosis, flow of diagnosis of PH, differential diagnosis of PH and how to determine the severity of PH are explained including recent development of magnetic resonance imaging (MRI) and gene abnormality study on BMPRII. In treatment, newly-developed pulmonary vasodilators are shown as well as how to combine them in PAH, and in CTEPH treatment the drugs, operation and catheter therapy including our experience are demonstrated.
Humans
;
Hypertension, Pulmonary
;
diagnosis
;
therapy